Company Filing History:
Years Active: 2016-2024
Title: Innovations and Contributions of Linda Johanna Aleida Hendriks in Utrecht, NL
Introduction
Linda Johanna Aleida Hendriks is a prominent inventor based in Utrecht, Netherlands, contributing significantly to the field of biochemistry and immunology. With a remarkable portfolio of 10 patents, Hendriks has been instrumental in developing novel methods and substances that advance therapeutic approaches.
Latest Patents
One of Hendriks' latest patents is titled "Methods and Means for the Production of Ig-Like Molecules." This invention provides innovative methods for producing one or more Ig-like molecules within a single host cell. It also introduces novel CH3 mutations that facilitate the production of monospecific and/or bispecific Ig-like molecules, enhancing their therapeutic potential.
Additionally, Hendriks has developed a patent focused on "Multivalent Antibody." This invention details a multivalent antibody comprising a base portion with two binding domains and at least one additional binding domain connected by a linker. Each binding domain features a common variable region, allowing the multivalent antibody to bind to at least three different epitopes, significantly impacting the effectiveness of antibody-based therapies.
Career Highlights
Linda Hendriks has held influential roles at prominent companies such as Merus N.V. and Merus B.V., where she has utilized her expertise to foster innovation in antibody engineering and related technologies.
Collaborations
Throughout her career, Hendriks has collaborated with esteemed professionals, including Cornelis Adriaan De Kruif and Ton Logtenberg. These collaborations have resulted in valuable advancements in their respective fields and contribute to the ongoing development of biopharmaceuticals.
Conclusion
Linda Johanna Aleida Hendriks exemplifies the impact of innovation in medicine through her significant patent contributions. Her work in developing new methods and proteins demonstrates a commitment to improving therapeutic applications and advancing science in Utrecht and beyond.